Pubblicazioni

31 01, 2018

Fabrizio Tabbò et. al, Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma

Diatech Pharmacogenetics2018-03-08T13:51:25+01:00

26 01, 2018

G. Ali’ et. al, Analysis of Fusion Genes by NanoString System A Role in Lung Cytology?

Diatech Pharmacogenetics2018-03-02T11:03:25+01:00

15 01, 2018

Veronique Tack et. al, RAS testing for colorectal cancer patients is reliable in European laboratories that pass external quality assessment

Diatech Pharmacogenetics2018-04-12T14:36:49+02:00

12 01, 2018

Elena Bonaparte et. al, Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry

Diatech Pharmacogenetics2018-03-08T13:45:37+01:00

12 01, 2018

Serena Trubini et al., Novel BRAF mutation in melanoma: A case report

Diatech Pharmacogenetics2018-02-01T13:12:10+01:00

9 01, 2018

M. Rosaria Raspollini et.al, Intratumoural heterogeneity may hinder precision medicine strategies in patients with clear cell renal cell carcinoma

Diatech Pharmacogenetics2018-01-15T11:18:58+01:00

27 12, 2017

Thibaut Kritter et. al, Radiomic Biomarkers Helps to Better Predict Progression Free Survival of Gliomas

Diatech Pharmacogenetics2018-03-08T13:56:50+01:00

7 12, 2017

Chiara Pesenti et. al, MassARRAY-based simultaneous detection of hotspot somatic mutations and recurrent fusion genes in papillary thyroid carcinoma: the PTC-MA assay

Diatech Pharmacogenetics2017-12-13T11:48:09+01:00

4 12, 2017

Susanna Cappia et. al, Detection of EGFR mutations in archival lung cancer samples by pyrosequencing

Diatech Pharmacogenetics2017-12-04T16:12:04+01:00

4 12, 2017

Giovanna De Maglio et. al, Sequenziamento mediante pyrosequencing: un’analisi rapida e sensibile per la determinazione delle mutazioni di EGFR nel carcinoma polmonare non a piccole cellule

Diatech Pharmacogenetics2017-12-04T16:06:50+01:00

Precedente 262728 Successivo